18F-FFNP

N/A

Report date: 2025/11/27 15:48:01
NME

Base Information

Drug Name18F-FFNP
Drug Alias Name18F-FFNP
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FSmall molecules > SteroidsRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionProgesterone receptor binders
TargetsProgesterone receptor
Therapy Area/IndicationsHR-positive breast cancerNeoplasm MetastasisBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteNational Institute of Health, Islamabad
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteUniversity Of Wisconsin-MadisonUniversity Of Washington
Inactive CompaniesWashington University School Of Medicine
Active IndicationsHR-positive breast cancerNeoplasm MetastasisBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A